Annual Drug Patent Expirations for TEGSEDI
Tegsedi is a drug marketed by Akcea Theraps and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.
This drug has five hundred and nineteen patent family members in thirty countries.
The generic ingredient in TEGSEDI is inotersen sodium. One supplier is listed for this compound. Additional details are available on the inotersen sodium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
